MSB

7.69%

$1.19 mesoblast limited

MSB trading, page-1535

First 1535 Last

Share
Profile

Follow
optimistus

4,653 Posts.

860

09/09/18

13:46

Post #: 35482659
Share

Originally posted by dolcevita ↑

You ignore the reality that shorting can and is, often part of an accumulation strategy.
When people gloat about how the shorters must be hurting, it must make them laugh. Because they're accumulating on the cheap!
Look who's doing that!

As for don't engage, obviously there are holders who only come into HC infrequently. It's poorly researched, weaker holders who are the low hanging fruit.

As for the bone-headed number crunches, that was my line AND it was well thought out. I'd appreciate it if you realised just how much effort I went to make my point clearly on this. Because Teva took over Cephalon, and there were sound scientists who remained at Teva and were part of actively getting a new protocol up in the FDA for stem cell tests.

If you cared to trawl back over years of posts, I actually predicted that the FDA would do this. For this I was sneered at.

It's perfectly reasonable to make the point that Teva was a company which made a series of short sighted decisions. Oversimplifications are dangerous, but I made the point about bone-headedness to illustrate an important principle. And nobody managed to counter this in a serious way. Teva paid far too much for other acquisitions for drug trials which failed and then had to divest themselves of anything that resembled a clinical trial. No matter how fundamentally different MSB clinical trials are from drug trials (the latter is high risk).

How about a bit less in the way of instructions about how others should post? Your contributions are valuable, and others might post to complement them, and offer other perspectives.

Just remember: traders love weak holders and people who act on emotion. They love to trigger an emotional decision.

All IMO.

Even if you think mine or other posters are repetitious, it's not for YOU personally. It's for people who infrequently come here and could get shaken out. Putting people on ignore is not a solution in that context. Think about it please. Thanks.

Expand

Yep, good point about some people only coming on here infrequently. Some poor souls might not realise you’ve been prattling on about the same topics for years.

I wonder how much those “weak hands” you were trying to save years ago (when the MSB share price was more than double what is is now) appreciated your comments.

I can think of no other poster on the entire site who has been more consistent in their repetition, nor for the inverse correlation between their sentiment for a stock and its share price.

This was the first random post of yours that came up for the date range I entered.

https://hotcopper.com.au/threads/by-msb.2411666/page-47?post_id=14381395#.W5ST5KR_WEc

MSB Price at posting: $1.63 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ASX hits all time high out the gate on Friday trades following bullish US inflation data

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

There are more pages in this discussion • 1,930 more messages in this thread...

First 1535 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.19		Change 0.085(7.69%)		Mkt cap ! $1.358B

Open	High	Low	Value	Volume
$1.10	$1.20	$1.09	$13.21M	11.37M

Buyers (Bids)

No.	Vol.	Price($)
1	15000	$1.19

Sellers (Offers)

Price($)	Vol.	No.
$1.19	75212	5

View Market Depth

No.	Vol.	Price($)
1	15000	1.185
1	20000	1.175
1	5664	1.170
1	17568	1.160
3	56695	1.150

Price($)	Vol.	No.
1.190	59712	2
1.195	36255	5
1.200	404381	31
1.205	3000	1
1.210	162475	7

Last trade - 16.10pm 12/07/2024 (20 minute delay)

MSB (ASX) Chart

MSB trading, page-1535

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Nimy to raise $1.21M to explore 'newsy' WA targets

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Immutep reports strong response rate from immunotherapies treating carcinomas

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MSB trading, page-1535

Top Stories

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Bitcoin investors need to know the risks

Nimy to raise $1.21M to explore 'newsy' WA targets

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Immutep reports strong response rate from immunotherapies treating carcinomas

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News